255 related articles for article (PubMed ID: 23028826)
1. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
[TBL] [Abstract][Full Text] [Related]
2. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
3. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
Garcia-Gomez M; Calabria A; Garcia-Bravo M; Benedicenti F; Kosinski P; López-Manzaneda S; Hill C; Del Mar Mañu-Pereira M; Martín MA; Orman I; Vives-Corrons JL; Kung C; Schambach A; Jin S; Bueren JA; Montini E; Navarro S; Segovia JC
Mol Ther; 2016 Aug; 24(7):1187-98. PubMed ID: 27138040
[TBL] [Abstract][Full Text] [Related]
4. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
Schwartz JD; Barcellini W; Grace RF; Bianchi P; Zanella A; López Lorenzo JL; Sevilla J; Shah AJ; Glader B; Nicoletti E; Navarro Ordoñez S; Segovia JC
Am J Hematol; 2022 Mar; 97(3):E120-E125. PubMed ID: 34989415
[No Abstract] [Full Text] [Related]
5. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.
Kiem HP; Wu RA; Sun G; von Laer D; Rossi JJ; Trobridge GD
Gene Ther; 2010 Jan; 17(1):37-49. PubMed ID: 19741733
[TBL] [Abstract][Full Text] [Related]
6. Foamy-virus-mediated gene transfer to canine repopulating cells.
Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
[TBL] [Abstract][Full Text] [Related]
7. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
[TBL] [Abstract][Full Text] [Related]
8. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.
Garate Z; Quintana-Bustamante O; Crane AM; Olivier E; Poirot L; Galetto R; Kosinski P; Hill C; Kung C; Agirre X; Orman I; Cerrato L; Alberquilla O; Rodriguez-Fornes F; Fusaki N; Garcia-Sanchez F; Maia TM; Ribeiro ML; Sevilla J; Prosper F; Jin S; Mountford J; Guenechea G; Gouble A; Bueren JA; Davis BR; Segovia JC
Stem Cell Reports; 2015 Dec; 5(6):1053-1066. PubMed ID: 26549847
[TBL] [Abstract][Full Text] [Related]
9. Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency.
Trobridge GD; Allen J; Peterson L; Ironside C; Russell DW; Kiem HP
Hum Gene Ther; 2009 May; 20(5):519-23. PubMed ID: 19199822
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of MGMT(P140K) and alpha-L-iduronidase in primary hepatocytes from mucopolysaccharidosis type I mice enables efficient selection with metabolic correction.
Wang D; Worsham DN; Pan D
J Gene Med; 2008 Mar; 10(3):249-59. PubMed ID: 18076130
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.
Zhao H; Pestina TI; Nasimuzzaman M; Mehta P; Hargrove PW; Persons DA
Blood; 2009 Jun; 113(23):5747-56. PubMed ID: 19365082
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
13. A pyruvate kinase deficiency child with novel PK-LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation.
Zhan LP; Que LP; Wu ZZ; Liu DD; Wang KM; Xu HG; Fang JP; Huang K
Pediatr Transplant; 2021 Nov; 25(7):e14078. PubMed ID: 34255916
[TBL] [Abstract][Full Text] [Related]
14. Optimized lentiviral vectors for HIV gene therapy: multiplexed expression of small RNAs and inclusion of MGMT(P140K) drug resistance gene.
Chung J; Scherer LJ; Gu A; Gardner AM; Torres-Coronado M; Epps EW; Digiusto DL; Rossi JJ
Mol Ther; 2014 May; 22(5):952-63. PubMed ID: 24576853
[TBL] [Abstract][Full Text] [Related]
15. Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency.
van Straaten S; Bierings M; Bianchi P; Akiyoshi K; Kanno H; Serra IB; Chen J; Huang X; van Beers E; Ekwattanakit S; Güngör T; Kors WA; Smiers F; Raymakers R; Yanez L; Sevilla J; van Solinge W; Segovia JC; van Wijk R
Haematologica; 2018 Feb; 103(2):e82-e86. PubMed ID: 29242305
[No Abstract] [Full Text] [Related]
16.
Rajawat YS; Humbert O; Cook SM; Radtke S; Pande D; Enstrom M; Wohlfahrt ME; Kiem HP
Hum Gene Ther; 2021 Jan; 32(1-2):113-127. PubMed ID: 32741228
[TBL] [Abstract][Full Text] [Related]
17. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
[TBL] [Abstract][Full Text] [Related]
18. In-Vivo Gene Therapy with Foamy Virus Vectors.
Rajawat YS; Humbert O; Kiem HP
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
20. F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells.
Maier P; Heckmann D; Spier I; Laufs S; Zucknick M; Allgayer H; Fruehauf S; Zeller WJ; Wenz F
Cancer Gene Ther; 2012 Nov; 19(11):802-10. PubMed ID: 23037811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
